Table 1.
Consensus domain and instrument for CTD-ILD and IPF groups (Modified from 7)
| Domains and Instrument | CTD-ILD consensus | IPF consensus |
|---|---|---|
| Dyspnea | ||
| MRC chronic dyspnea scale | 75% | 92% |
| Dyspnea 12 | 88% | 70% |
| UCSD-SBQ | NA | 80% |
| Cough | ||
| Leicester cough monitor | 79% | 82% |
| HRQoL | ||
| Short form 36 | 100% | 82% |
| SGRQ | 87% | 82% |
| VAS-PtGA | 96% | NA |
| Lung Imaging | ||
| Overall extent of ILD on HRCT | 92% | 100% |
| Lung physiology | ||
| Forced vital capacity | 100% | 100% |
| Diffusion capacity of lung | 91% | 100% |
| Survival | ||
| All cause mortality | 100% | 100% |
Footnote: CTD-ILD: Connective tissue disease associated interstitial lung disease; HRCT: High resolution CT; HRQoL: health related quality of life; IPF: idiopathic pulmonary fibrosis; MRC: Medical Research Council; PtGA: Patient global assessment; SGRQ: St George’s Respiratory Questionnaire; UCSD-SBQ: University of California San Diego Shortness of Breath Questionnaire; VAS: visual analogue scale.